. . . . . . . . . . . "p(HGNC:VEGFA) -| bp(MESHPP:Apoptosis)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "How does 'resistance' occur? In addition to the hypoxia that often naturally accompanies tumour growth, anti-angiogenesis treatments can also contribute to hypoxia - an expected result of the loss of the oxygen-transporting blood vessels66.Unfortunately, hypoxia and high levels of VEGFA production provide some protection from cytotoxic drugs by inducing expression of anti-apoptotic genes" . . "Selventa" . . . . "2014-07-03T14:30:12.955+02:00"^^ . . .